JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schumacher, H.
Right arrow Articles by Gillette, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schumacher, H.
Right arrow Articles by Gillette, J. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DIMETHYL SULFOXIDE
*METHYL CELLULOSE
*THALIDOMIDE
*TRITIUM
Journal of Pharmacology And Experimental Therapeutics, Vol. 160, Issue 1, 201-211, 1968
Copyright © 1968 by American Society for Pharmacology and Experimental Therapeutics

DISPOSITION OF THALIDOMIDE IN RABBITS AND RATS

Herbert Schumacher 1, David A. Blake 1, and James R. Gillette 1

1 Laboratory of Chemical Pharmacology, National Heart Institute, National Institutes of Health, Bethesda, Maryland

The rates of absorption, metabolism and excretion of thalidomide were compared in rabbits and rats. The half-life of the drug was virtually the same (2-3 hr) in rats, rabbits and pH 7.4 buffer. The absorption of orally administered thalidomide was more rapid in rabbits than in rats and the time-course for the elimination of metabolites was different in the two species. Although thalidomide is metabolized mainly by spontaneous hydrolysis in various tissues, the rate of breakdown is considerably greater in rabbit liver. Evidence is presented indicating that thalidomide in both species becomes bound to tissue components, possibly by covalent bonds.

Submitted on June 21, 1967
Accepted on October 25, 1967




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
J. Lu, N. Helsby, B. D. Palmer, M. Tingle, B. C. Baguley, P. Kestell, and L.-M. Ching
Metabolism of Thalidomide in Liver Microsomes of Mice, Rabbits, and Humans
J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 571 - 577.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
I. K. Aronson, R. Yu, D. P. West, H. Van Den Broek, and J. Antel
Thalidomide-Induced Peripheral Neuropathy: Effect of Serum Factor on Nerve Cultures
Arch Dermatol, November 1, 1984; 120(11): 1466 - 1470.
[Abstract] [PDF]

Home page
 Arch DermatolHome page
H. van den Broek
Treatment of Prurigo Nodularis With Thalidomide
Arch Dermatol, May 1, 1980; 116(5): 571 - 572.
[Abstract] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics.